Market Cap

Fusion Antibodies plc Market Capitalization:

£15.8 Million

GBP as of Jan. 1, 2026

US$21.3 Million

business Fusion Antibodies plc Company Profile

Fusion Antibodies plc Main Stock Listing

LSE: FAB

Market Capitalization History of Fusion Antibodies plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Fusion Antibodies plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £15.8 M 76.53%
Jan. 1, 2025 £9.0 M 254.68%
Jan. 1, 2024 £2.5 M -83.68%
Jan. 1, 2023 £15.5 M -46.35%
Jan. 1, 2022 £28.9 M -18.30%
Jan. 1, 2021 £35.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Fusion Antibodies plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Fusion Antibodies plc has the following listings and related stock indices.


Stock: LSE: FAB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.